Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Gsk (GLAXF) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Gsk (GLAXF) over the last 17 years, with Q3 2025 value amounting to $2.9 billion.

  • Gsk's Other Non-Current Assets rose 1410.46% to $2.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 billion, marking a year-over-year increase of 1410.46%. This contributed to the annual value of $2.5 billion for FY2024, which is 2599.69% up from last year.
  • Per Gsk's latest filing, its Other Non-Current Assets stood at $2.9 billion for Q3 2025, which was up 1410.46% from $2.7 billion recorded in Q2 2025.
  • Gsk's Other Non-Current Assets' 5-year high stood at $2.9 billion during Q3 2025, with a 5-year trough of $32.2 million in Q1 2022.
  • Over the past 5 years, Gsk's median Other Non-Current Assets value was $2.0 billion (recorded in 2023), while the average stood at $1.9 billion.
  • As far as peak fluctuations go, Gsk's Other Non-Current Assets tumbled by 9763.86% in 2022, and later surged by 554650.11% in 2023.
  • Over the past 5 years, Gsk's Other Non-Current Assets (Quarter) stood at $2.3 billion in 2021, then tumbled by 38.01% to $1.4 billion in 2022, then skyrocketed by 40.38% to $2.0 billion in 2023, then grew by 26.78% to $2.5 billion in 2024, then increased by 15.39% to $2.9 billion in 2025.
  • Its Other Non-Current Assets stands at $2.9 billion for Q3 2025, versus $2.7 billion for Q2 2025 and $2.5 billion for Q1 2025.